Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Finbar Slevin

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 24, 2023
Neurocognitive function following (chemo)radiotherapy for nasopharyngeal cancer and other head and neck cancers: A systematic reviewZsuzsanna Iyizoba-Ebozue, Robin Prestwich, Sarah Brown, et al.
International Journal of Radiation Oncology, Biology, Physics|March 14, 2026
Constraints, cumulative doses and toxicity outcomes in glioma reirradiation: a systematic review and radiobiological comparison from the Reirradiation Collaborative Group (ReCog)Finbar Slevin, Xuguang Scott Chen, Benjamin S Rosen, et al.
Technical Innovations & Patient Support in Radiation Oncology|March 21, 2024
"Why am I still suffering?": Experience of long-term fatigue and neurocognitive changes in oropharyngeal cancer survivors following (chemo)radiotherapyZsuzsanna Iyizoba-Ebozue, Emma Nicklin, James Price, et al.
Clinical and Translational Radiation Oncology|May 6, 2020
Efficacy and toxicity outcomes for patients treated with focal salvage high dose rate brachytherapy for locally recurrent prostate cancerFinbar Slevin, Samantha Hodgson, Sree Lakshmi Rodda, et al.
Clinical and Translational Radiation Oncology|November 9, 2019
A comparison of outcomes for patients with intermediate and high risk prostate cancer treated with low dose rate and high dose rate brachytherapy in combination with external beam radiotherapyFinbar Slevin, Sree Lakshmi Rodda, Peter Bownes, et al.
Clinical and Translational Radiation Oncology|July 9, 2020
Response to 'Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer'Finbar Slevin, Sree Lakshmi Rodda, Peter Bownes, et al.
Journal of Cancer Survivorship : Research and Practice|January 18, 2025
Multidimensional fatigue and its impact on work productivity, mood and quality of life in long-term survivors following definitive intensity-modulated radiotherapy for oropharyngeal cancer: A cross-sectional studyZsuzsanna Iyizoba-Ebozue, Emma Nicklin, Stuart Currie, et al.
Journal of Cancer Survivorship : Research and Practice|August 1, 2025
Neurocognitive concerns and neurocognitive impairment in long-term survivors of oropharyngeal cancer post (chemo)radiotherapyZsuzsanna Iyizoba-Ebozue, Robin Prestwich, Maryse Luijendijk, et al.
BMJ Open|March 8, 2024
Brain Re-Irradiation Or Chemotherapy: a phase II randomised trial of re-irradiation and chemotherapy in patients with recurrent glioblastoma (BRIOChe) - protocol for a multi-centre open-label randomised trialEleanor M Hudson, Samantha Noutch, Joanne Webster, et al.
BMJ Open|December 26, 2024
Pelvis Or Involved Node Treatment: Eradicating Recurrence in Prostate Cancer (POINTER-PC) - study protocol paper for a phase III multicentre, open-label randomised controlled trialFinbar Slevin, Sophie Alexander, Sarah R Brown, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 24, 2023
Neurocognitive function following (chemo)radiotherapy for nasopharyngeal cancer and other head and neck cancers: A systematic reviewZsuzsanna Iyizoba-Ebozue, Robin Prestwich, Sarah Brown, et al.
International Journal of Radiation Oncology, Biology, Physics|March 14, 2026
Constraints, cumulative doses and toxicity outcomes in glioma reirradiation: a systematic review and radiobiological comparison from the Reirradiation Collaborative Group (ReCog)Finbar Slevin, Xuguang Scott Chen, Benjamin S Rosen, et al.
Technical Innovations & Patient Support in Radiation Oncology|March 21, 2024
"Why am I still suffering?": Experience of long-term fatigue and neurocognitive changes in oropharyngeal cancer survivors following (chemo)radiotherapyZsuzsanna Iyizoba-Ebozue, Emma Nicklin, James Price, et al.
Clinical and Translational Radiation Oncology|May 6, 2020
Efficacy and toxicity outcomes for patients treated with focal salvage high dose rate brachytherapy for locally recurrent prostate cancerFinbar Slevin, Samantha Hodgson, Sree Lakshmi Rodda, et al.
Clinical and Translational Radiation Oncology|November 9, 2019
A comparison of outcomes for patients with intermediate and high risk prostate cancer treated with low dose rate and high dose rate brachytherapy in combination with external beam radiotherapyFinbar Slevin, Sree Lakshmi Rodda, Peter Bownes, et al.
Clinical and Translational Radiation Oncology|July 9, 2020
Response to 'Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer'Finbar Slevin, Sree Lakshmi Rodda, Peter Bownes, et al.
Journal of Cancer Survivorship : Research and Practice|January 18, 2025
Multidimensional fatigue and its impact on work productivity, mood and quality of life in long-term survivors following definitive intensity-modulated radiotherapy for oropharyngeal cancer: A cross-sectional studyZsuzsanna Iyizoba-Ebozue, Emma Nicklin, Stuart Currie, et al.
Journal of Cancer Survivorship : Research and Practice|August 1, 2025
Neurocognitive concerns and neurocognitive impairment in long-term survivors of oropharyngeal cancer post (chemo)radiotherapyZsuzsanna Iyizoba-Ebozue, Robin Prestwich, Maryse Luijendijk, et al.
BMJ Open|March 8, 2024
Brain Re-Irradiation Or Chemotherapy: a phase II randomised trial of re-irradiation and chemotherapy in patients with recurrent glioblastoma (BRIOChe) - protocol for a multi-centre open-label randomised trialEleanor M Hudson, Samantha Noutch, Joanne Webster, et al.
BMJ Open|December 26, 2024
Pelvis Or Involved Node Treatment: Eradicating Recurrence in Prostate Cancer (POINTER-PC) - study protocol paper for a phase III multicentre, open-label randomised controlled trialFinbar Slevin, Sophie Alexander, Sarah R Brown, et al.
Pageof 3